Compare Cronos Group Inc (CRON) vs IONQ Inc (IONQ) Price & Performance

CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.

Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.

IONQ shares declined 9.29% to $38.88 amid broader quantum computing sector weakness, though technical indicators show oversold conditions with RSI at 16.05. The company maintains a mixed fundamental picture with strong revenue growth projections ($130M in 2025 to $187M in 2026) but significant operating losses. Analyst sentiment remains divided with a 50/50 buy/hold split despite a consensus price target of $73.75 representing 90% upside potential from current levels.

The stock presents high-risk, high-reward potential with Wall Street recognizing IONQ's leadership in trapped-ion quantum computing technology but concerned about cash burn and execution risks. Near-term catalysts include Q2 2026 earnings and the planned 256-qubit system demonstration, though the stock faces volatility from speculative trading and competitive pressures in the emerging quantum sector.